Navigation Links
Study Reveals Better Results in Patients Suffering From Depression.

Patients suffer from various psychiatric disease and they throng the hospitals for treatment. Statistics show that a third of these people // suffer from mental depressions of different levels.

Drugs that are used to treat them had a lot of controversial opinion about them and hence a study was conducted to analyze the effect of these drugs on the patients.

The initial results were that the drugs showed better results in case of well-qualified white women. The patients seem to undergo better recovery in their first trail of antidepressants. Dr. Madhukar Trivedi at the University of Texas Southwestern Medical Center carried out this study, which was funded by the National Institute of Mental Health ($35 million).

But in the earlier times treating patients with depression was a very challenging task. The first set of antidepressants will not usually work with the patients and the doctors would have to mix and match various drugs in order to find the exact cure for the particular patient.

The study (STAR-D) involved monitoring of the doctors especially in the initial months of the antidepressant’s usage.

The main idea to go about with this study is that there were evidences proving that antidepressants on certain periods led to increased suicidal tendencies in children/teenagers.

The Food and Drug Administration (FDA) has ordered that the pharmaceutical companies include the risks of children on the product labels. The study also said that in the future they would analyze the adult risk of usage of these antidepressants.

The results of the study were that it did not show any suicidal tendencies among the subjects (3000) included in the study.

The STAR-D study, which is a six-year study, was analyzed in two steps.

In step one the patients were given a newer class of antidepressants of selective serotonin reuptakes (Celexa). It showed that white women who were well qualified and patients who
'"/>




Page: 1 2

Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...ent (chemotherapy) given to patients with disorder...eatment// of the much dreaded bird flu. The treat...ers. An immune system disorder referred to as haem...is similar in a lot of ways to the bird flu infect...
...e University of California, Irvine (UCI) and also ...perimental drug// AF267B is effective against both...se in mice. This compound (AF267B) curbs both the... Alzheimer's-affected brains, as well as another l...
...inancial shape following the bird flu scare in the...ltry farmers organized a "chicken party" here to b...zed the party to remove the fright from people's m...cretary of the Gujarat Broiler Farmers' Associatio...
...he super-specialty hospitals in Delhi on standby i... two hospitals are - Sir Ganga Ram Hospital and In...ted our facilities, found our services were to the...signating us as the standby hospital for the US pr...
Other Medicine News:Health News:Anti-Cancer Treatment Promises Hope in Bird Flu Treatment 2Health News:Experimental Alzheimer’s Drug curbs the disease in mic 2
(Date:9/4/2008)...ept. 4 /- BioForm Medical,...otal clinical study of,Polidocanol, conducted in G...rik KREUSSLER & Co. GmbH (Kreussler), successfully...tted to FDA as part of a New Drug Application,(NDA...the EASI (Efficacy and safety of,Aethoxysklerol co...
(Date:9/4/2008)...n ,The Lancet, and Presented at ESC Congress-, PH... new international,study, the GISSI Heart Failure ...3 acid ethyl esters reduced all cause mortality an...n patients with chronic heart,failure. These findi... ,The,Lancet, and were presented at the European C...
(Date:9/4/2008)...pt. 4 /- Southern Research Institute,...alth (NIH) has selected,the organization to partic...e Production Center Network (MLPCN). The MLPCN -- ... Molecular Libraries Program which is,designed to ... of the human,genome and validate future targets f...
(Date:9/4/2008)... September 4 /- Axentis Pharma AG has...e safety and tolerability,of a new therapeutic for...ection in cystic fibrosis patients. The new formul...e delivered directly to the site of,infection. The...f two,different doses of the new drug. Initial res...
Breaking Medicine Technology:338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Strategies to control TB outdated inadequate 24851 1Strategies to control TB outdated inadequate 24851 2Immune system protein accurate predictor of survival in pediatric septic shock 4305 1Immune system protein accurate predictor of survival in pediatric septic shock 4305 2Immune system protein accurate predictor of survival in pediatric septic shock 4305 3HealthFitness Guides Incentives Strategy to Spark Participation in American Electric Power 26apos 3Bs Employee Health and Wellness Initiative New Issu 24849 1HealthFitness Guides Incentives Strategy to Spark Participation in American Electric Power 26apos 3Bs Employee Health and Wellness Initiative New Issu 24849 2HealthFitness Guides Incentives Strategy to Spark Participation in American Electric Power 26apos 3Bs Employee Health and Wellness Initiative New Issu 24849 3DIY Disasters Cost the Average Brit 669 58 Says Confused com 24847 1DIY Disasters Cost the Average Brit 669 58 Says Confused com 24847 2DIY Disasters Cost the Average Brit 669 58 Says Confused com 24847 3
..., 2007 - VGX Pharmaceuticals,novel pandemic influ...e responses in pre-clinical challenge studies, acc...at the Third International,Conference on DNA Vacci... synthetic consensus DNA vaccines to,protect again...za,in mice. One of the vaccines resulted in comple...
...-FirstCall/ -- CEL-SCI,CORPORATION announces that ...avian influenza antigen in combination with MAS-1,...ndings were,presented on May 23, 2007 by Dr. Danie...llular Immunology at CEL-SCI at the,American Socie... in,Toronto, Canada. , This new finding with CEL-1...
Other Medicine Technology:VGX Pharmaceuticals' Novel HIV and Pandemic Influenza DNA Vaccine,Candidates Trigger Robust Immune Responses and Protection in,Pre-Clinical Models 2CEL-SCI'S CEL-1000 Shown to Significantly Enhance Immune Response,Against Avian Flu Antigen in Animals 2
...vailable at manufacturer-direct prices. We set th...g superior quality withunmatched customer support....rt, SheerVision loupes are the clear choice for me...pes come compete with clear lens covers, fully-lin...
...ers superior illumination in a lightweight, go-any...powerful, long-lasting illumination with unrestric.... High center-beam brightness and hands-free opera...rechargeable battery provides over five hours of u...
Easy pull-on garment's feature Rainey's exclusive Non-Slip Dome™design and adjustable Velcro© closure at neck for optimal comfort and support. Choose covered or non covered ear design.
A CDI original design with seams on the outside, away from the skin, adjustable fit and removable/adjustable back strap, provides patient comfort and needed compression.
Medicine Products: